61 bivirkninger fra spontan rapportering, for hvilke der ikke blev observeret tilfælde i de randomiserede placebo- kontrollerede patientforsøg med mirtazapin, er klassificeret som ‘ ikke kendt ’.
The frequency of adverse reactions from spontaneous reporting for which no cases in the randomized placebo-controlled patient trials were observed with mirtazapine has been classified as ‘ not known’.